Literature DB >> 24797573

Contribution of six risk factors to achieving the 25×25 non-communicable disease mortality reduction target: a modelling study.

Vasilis Kontis1, Colin D Mathers2, Jürgen Rehm3, Gretchen A Stevens2, Kevin D Shield4, Ruth Bonita5, Leanne M Riley6, Vladimir Poznyak7, Robert Beaglehole5, Majid Ezzati8.   

Abstract

BACKGROUND: Countries have agreed to reduce premature mortality (defined as the probability of dying between the ages of 30 years and 70 years) from four main non-communicable diseases (NCDs)--cardiovascular diseases, chronic respiratory diseases, cancers, and diabetes--by 25% from 2010 levels by 2025 (referred to as 25×25 target). Targets for selected NCD risk factors have also been agreed on. We estimated the contribution of achieving six risk factor targets towards meeting the 25×25 mortality target.
METHODS: We estimated the impact of achieving the targets for six risk factors (tobacco and alcohol use, salt intake, obesity, and raised blood pressure and glucose) on NCD mortality between 2010 and 2025. Our methods accounted for multi-causality of NCDs and for the fact that when risk factor exposure increases or decreases, the harmful or beneficial effects on NCDs accumulate gradually. We used data for risk factor and mortality trends from systematic analyses of available country data. Relative risks for the effects of individual and multiple risks, and for change in risk after decreases or increases in exposure, were from re-analyses and meta-analyses of epidemiological studies.
FINDINGS: If risk factor targets are achieved, the probability of dying from the four main NCDs between the ages of 30 years and 70 years will decrease by 22% in men and by 19% in women between 2010 and 2025, compared with a decrease of 11% in men and 10% in women under the so-called business-as-usual trends (ie, projections based on current trends with no additional action). Achieving the risk factor targets will delay or prevent more than 37 million deaths (16 million in people aged 30-69 years and 21 million in people aged 70 years or older) from the main NCDs over these 15 years compared with a situation of rising or stagnating risk factor trends. Most of the benefits of achieving the risk factor targets, including 31 million of the delayed or prevented deaths, will be in low-income and middle-income countries, and will help to reduce the global inequality in premature NCD mortality. A more ambitious target on tobacco use (a 50% reduction) will almost reach the target in men (>24% reduction in the probability of death), and enhance the benefits to a 20% reduction in women.
INTERPRETATION: If the agreed risk factor targets are met, premature mortality from the four main NCDs will decrease to levels that are close to the 25×25 target, with most of these benefits seen in low-income and middle-income countries. On the basis of mortality benefits and feasibility, a more ambitious target than currently agreed should be adopted for tobacco use. FUNDING: UK MRC.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24797573     DOI: 10.1016/S0140-6736(14)60616-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  135 in total

1.  The Effects of Two Influential Early Childhood Interventions on Health and Healthy Behaviour.

Authors:  Gabriella Conti; James Heckman; Rodrigo Pinto
Journal:  Econ J (London)       Date:  2016-12-07

2.  Body mass index and infectious disease mortality in midlife in a cohort of 2.3 million adolescents.

Authors:  G Twig; N Geva; H Levine; E Derazne; N Goldberger; Z Haklai; A Leiba; J D Kark
Journal:  Int J Obes (Lond)       Date:  2017-10-30       Impact factor: 5.095

Review 3.  Harnessing centred identity transformation to reduce executive function burden for maintenance of health behaviour change: the Maintain IT model.

Authors:  Ann E Caldwell; Kevin S Masters; John C Peters; Angela D Bryan; Jim Grigsby; Stephanie A Hooker; Holly R Wyatt; James O Hill
Journal:  Health Psychol Rev       Date:  2018-02-19

Review 4.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

Review 5.  Use of mHealth systems and tools for non-communicable diseases in low- and middle-income countries: a systematic review.

Authors:  David Peiris; Devarsetty Praveen; Claire Johnson; Kishor Mogulluru
Journal:  J Cardiovasc Transl Res       Date:  2014-09-11       Impact factor: 4.132

6.  Prevention: Relating risk factor reduction to disease risk on a global level.

Authors:  Peter Sidaway
Journal:  Nat Rev Cardiol       Date:  2014-05-20       Impact factor: 32.419

7.  How intensive longitudinal data can stimulate advances in health behavior maintenance theories and interventions.

Authors:  Genevieve F Dunton; Alexander J Rothman; Adam M Leventhal; Stephen S Intille
Journal:  Transl Behav Med       Date:  2021-02-11       Impact factor: 3.046

8.  Positive Psychology in Lifestyle Medicine and Health Care: Strategies for Implementation.

Authors:  Liana S Lianov; Barbara L Fredrickson; Carrie Barron; Janani Krishnaswami; Anne Wallace
Journal:  Am J Lifestyle Med       Date:  2019-04-18

Review 9.  Usefulness of the Polypill for the Prevention of Cardiovascular Disease and Hypertension.

Authors:  Steven G Chrysant; George S Chrysant
Journal:  Curr Hypertens Rep       Date:  2016-02       Impact factor: 5.369

Review 10.  The Global Burden of Cardiovascular Disease in Women.

Authors:  Shilpa Sharma; Malissa J Wood
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.